T-Checks Crackdown Hits Troops 30+

Gloved hand holding a blood sample tube — Photo: angellodeco / Shutterstock

The Pentagon just made testosterone testing mandatory for troops 30 and older, and Defense Secretary Pete Hegseth says it’s about rebuilding a stronger, more capable fighting force.

Story Snapshot

Defense Health Agency guidance now requires annual testosterone screening for male active-duty and reserve troops aged 30 and up.
The protocol uses two morning blood draws, not one, before anyone gets a diagnosis of low testosterone.
Treatment is described as voluntary and aimed at fixing a real medical problem, not boosting performance.
The Endocrine Society and some doctors say mass screening of healthy men isn’t backed by solid evidence.
Questions remain about cost, false positives, and how the Pentagon handles refusals.

New Rule Targets Men 30 and Older

The Defense Health Agency has turned Hegseth’s testosterone push into real clinical policy, not just talk. Male troops 30 and older must now get screened yearly during their standard health checkup. Younger troops can ask for testing too, or get screened if a doctor spots symptoms worth checking out. It’s a sweeping change for a force the Pentagon says needs to be sharper and stronger.

This isn’t a snap judgment based on one bad blood test. The guidance calls for testing on two separate mornings, and anyone below 300 nanograms per deciliter gets a closer medical look before any diagnosis sticks. The Food and Drug Administration backs that same cautious standard, saying testosterone checks should involve at least two draws, usually under that same threshold.

Restoring Readiness, Not Chasing Super-Soldiers

Chief Pentagon spokesman Sean Parnell framed the program as setting a baseline for the entire force and offering real help to troops who actually need it. He said the goal is sustaining a capable fighting force, not handing out performance drugs. The policy stays voluntary, and treatment only follows an actual diagnosis of low testosterone, not just a single low number on a chart.

The Food and Drug Administration already approves testosterone treatment for men who have low levels tied to a real medical condition, not just because of age. That lines up with what the Pentagon says it’s doing here. Supporters see this as common sense: find a real problem, confirm it twice, then treat it. That’s basic medicine, not ideology.

Doctors Warn the Net May Be Too Wide

Not everyone is convinced. The Endocrine Society says there isn’t enough evidence to justify screening every man over 30, even if he feels totally fine. The group warns that testing a whole age group this way is likely to flag a lot of men as “low” who don’t actually have a medical problem, creating unnecessary worry and extra appointments.

A military-focused research letter raised a similar flag, warning that routine screening could trigger a wave of repeat testing, counseling sessions, and follow-up visits across the force. CNN medical contributor Dr. Jonathan Reiner went further, calling the original policy “embarrassing” and arguing a low number doesn’t mean much if the service member feels great and shows no symptoms at all.

Rocky Rollout Fuels Skepticism

The rollout hasn’t exactly been smooth. The Pentagon posted guidance in September covering both men and women, pulled it down the very next day calling it an unfinished draft, then later reissued a version focused mainly on men. That back-and-forth gives critics ammunition to call the policy rushed, even though the underlying medical goal, catching real hypogonadism, remains sound and worth pursuing carefully.

Why exactly would the Department of Defense be investing hundreds of millions in taxpayers dollars in a pharmaceutical manufacturer anywhere in America? Probably so they can ramp up production of testosterone for all the new users that Hegseth has caused.

— John Thomas (@JohnThomaso64) October 18, 2026

Questions also remain about what happens to female service members under this framework, since the mandatory piece focuses on men while earlier announcements sounded broader. Nobody has published a clear budget estimate either, and taxpayers deserve to know what confirmatory testing, counseling, and long-term treatment will actually cost the Pentagon.

What Comes Next for the Force

For conservatives who want a leaner, stronger, less bureaucratic military, the testosterone push fits a broader theme: cutting through soft policies and focusing on hard readiness. Hegseth has made no secret that he wants a warrior-focused culture back in the ranks. If this program catches real medical problems and gets troops back to full strength, it’s worth doing right, with clear rules, honest costs, and protection against political and career pressure on the men who get tested.